NEW YORK, July 23 (GenomeWeb News) - Ipsogen will provide microarray-based services to industrial and academic customers based on Affymetrix's technology, the Marseille, France-based company said today.
As an "authorized service provider" for Affymetrix technology, Ipsogen will add Affymetrix's GeneChip system to its research services. The company's services focus on the molecular diagnosis of cancer and the discovery and development of anti-cancer drugs.